Blog
About

1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A one-year trial of tiotropium Respimat plus usual therapy in COPD patients.

      Respiratory Medicine

      Aged, Bronchodilator Agents, administration & dosage, adverse effects, Disease Progression, Double-Blind Method, Female, Forced Expiratory Volume, drug effects, physiology, Humans, Male, Patient Compliance, Pulmonary Disease, Chronic Obstructive, drug therapy, mortality, physiopathology, Respiratory Function Tests, Scopolamine Derivatives, Smoking

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this randomised double-blind study, patients >or=40 years old with COPD, a smoking history of >or=10 pack-years, a pre-bronchodilator FEV(1) of

          Related collections

          Author and article information

          Journal
          20620037
          10.1016/j.rmed.2010.06.004

          Comments

          Comment on this article